Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Prost · SciRah

Researcher profile · Semantic Scholar

D. Prost

Share profile

D. Prost — researcher profile on SciRah

h-index: 4
Works: 21
Citations: 50

Most-cited papers

Systemic treatments in recurrent or metastatic salivary gland cancer: a systematic review
D. Prost, S. Iseas, M. Gatineau, J. Adam +4 more
2024ESMO Open21 citations Open access
Semantic Scholar
Mutational burden and immune recognition of gliomas
D. Prost, F. Bielle, K. Ligon, M. Touat
2021Current Opinion in Oncology6 citations Open access
Semantic Scholar
Effects of time to chemoradiation on high-grade gliomas from the Buenos Aires Metropolitan Area
D. Prost, M. Merenzon, J. I. Gómez-Escalante, A. Primavera +10 more
2021PLoS ONE6 citations Open access
Semantic Scholar
Surgical approach to the treatment of pituicytoma. Report of five cases and a literature review.
M. E. Yasuda, Rodolfo Recalde, P. Jalón, D. Prost +2 more
2023World Neurosurgery: X5 citations Open access
Semantic Scholar
Resistance of recurrent epidermal growth factor receptor-altered glioblastoma to anti-epidermal growth factor receptor targeted therapy with osimertinib
F. Villanacci, D. Prost, F. Pieri, J. Boetto +10 more
2025The Oncologist3 citations Open access
Semantic Scholar
Prognostic Factors of Long-Term Outcomes after Primary Chemo-Radiotherapy in Non-Metastatic Anal Squamous Cell Carcinoma: An International Bicentric Cohort
S. Iseas, D. Prost, S. Bouchereau, M. Golubicki +13 more
2023Biomedicines3 citations Open access
Semantic Scholar
Preoperative imaging features: Are they useful tools for predicting IDH1 mutation status in gliomas Grades II–IV?
M. Merenzon, Jose Ignacio Gómez Escalante, D. Prost, E. Seoane +2 more
2022Surgical neurology international2 citations Open access
Semantic Scholar
18F-DOPA-PET and advanced MRI improve treatment response assessment in IDH1/2-mutant gliomas treated with IDH inhibitors.
D. Prost, L. Nichelli, Laura Rozenblum, A. Laurenge +14 more
2026Clinical Cancer Research1 citations
Semantic Scholar
Which biological pathways are responsible for the late appearance of brain metastases in renal cell carcinoma? Analysis of eight cases
Federico E. Minghinelli, Rodolfo Recalde, D. Prost, H. Cutuli +2 more
2022Surgical neurology international1 citations Open access
Semantic Scholar
[Algorithm for the integrated diagnosis of gliomas 2021. Our experience].
M. Merenzon, José Ignacio Gómez Escalante, D. Prost, E. Seoane +2 more
2022Medicina1 citations
Semantic Scholar
Anaplastic oligoastrocytoma with dual genotype: A case report of a rare entity.
M. Merenzon, José Gomez Escalante, D. Prost, L. Marino +2 more
2020Clinical Neuropathology1 citations
Semantic Scholar
Manejo de toxicidades por inmunoterapias
D. Prost, Gabriela Cinat
2017Oncología Clínica1 citations Open access
Semantic Scholar
Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma
Diana D. Shi, Ester Calvo Fernández, V. Puliyappadamba, T. Lanman +41 more
2026Science Translational Medicine0 citations Open access
Semantic Scholar
Transcriptomic immune-related signature associated with chemoradiotherapy response in anal squamous cell carcinoma
S. Iseas, M. Golubicki, E. Lacunza, D. Prost +6 more
2026Scientific Reports0 citations Open access
Semantic Scholar
Transcriptomic Immune-related Signature Predictive of Chemoradiotherapy Response in Anal Squamous Cell Carcinoma
S. Iseas, M. Golubicki, E. Lacunza, D. Prost +6 more
2026medRxiv0 citations Open access
Semantic Scholar
Harnessing transcriptome signatures and CD103+CD8+ immune infiltration for prognosis and treatment outcomes in anal squamous cell carcinoma.
I. S. Iseas, M. Golubicki, E. Lacunza, D. Prost +5 more
2025Journal of Clinical Oncology0 citations
Semantic Scholar
Effect of 18F-DOPA-PET and advanced MRI on treatment response assessment in IDH1/2-mutant gliomas treated with IDH inhibitors.
D. Prost, L. Nichelli, Laura Rozenblum, A. Laurenge +14 more
2025Journal of Clinical Oncology0 citations Open access
Semantic Scholar
TMOD-12. Preclinical and clinical assessment of chemoradiation after mutant IDH inhibitor treatment in IDH-mutant glioma
Diana D. Shi, E. Calvo-Fernández, V. Puliyappadamba, T. Lanman +31 more
2025Neuro-Oncology0 citations
Semantic Scholar
Experiencia institucional en pacientes portadores de melanoma irresecable/metastásico con mutaciones infrecuentes de BRAF, tratados con anti PD-1
Pedro Bence, Evelina Rovera, D. Prost, A. Llanos +2 more
2018Oncología Clínica0 citations Open access
Semantic Scholar
Experiencia de una institución argentina en tumores neuroendocrinos de cérvix
Sofía Pujovich, E. O. Ortega Chahla, Andrés Gil, F. Alsina +1 more
2017Oncología Clínica0 citations Open access
Semantic Scholar
Investigating novel biomarkers linked to tumor progression and targeted therapy response in IDH1/2-mutant gliomas
D. Prost
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Touat×6
Invite
M. Touat — researcher profile on SciRah
S. Iseas×4
Invite
S. Iseas — researcher profile on SciRah
M. Merenzon×4
Invite
M. Merenzon — researcher profile on SciRah
Alejandro Mazzón×4
Invite
Alejandro Mazzón — researcher profile on SciRah

×4

Invite

S. Bouchereau — researcher profile on SciRah

M. Golubicki×4

Invite

M. Golubicki — researcher profile on SciRah

N. Baba-Hamed×4

Invite

N. Baba-Hamed — researcher profile on SciRah

Invite

F. Bielle — researcher profile on SciRah

R. Zaninovich×3

Invite

R. Zaninovich — researcher profile on SciRah

Julian Jacob×3

Invite

Julian Jacob — researcher profile on SciRah

Invite

L. Nichelli — researcher profile on SciRah

Invite

C. Dehais — researcher profile on SciRah